318 related articles for article (PubMed ID: 8336839)
1. [Role of laboratory monitoring in oral anticoagulant therapy].
D'Angelo G; Calvano D; Giardini C
Minerva Med; 1993 Jun; 84(6):313-22. PubMed ID: 8336839
[TBL] [Abstract][Full Text] [Related]
2. [Biological monitoring of treatment with antivitamin K. Value of INR and definition of new therapeutic ranges. A study of 73 patients].
Gouin I; Horellou MH; Conard J; Samama M
Arch Mal Coeur Vaiss; 1990 Mar; 83(3):357-61. PubMed ID: 2108630
[TBL] [Abstract][Full Text] [Related]
3. International standardization of laboratory control of oral anticoagulant therapy: a survey of thromboplastin reagents used for prothrombin time testing.
van den Besselaar AM
J Heart Valve Dis; 1993 Jan; 2(1):42-52. PubMed ID: 8269109
[TBL] [Abstract][Full Text] [Related]
4. Comparison of a chromogenic factor X assay with international normalized ratio for monitoring oral anticoagulation therapy.
McGlasson DL; Romick BG; Rubal BJ
Blood Coagul Fibrinolysis; 2008 Sep; 19(6):513-7. PubMed ID: 18685434
[TBL] [Abstract][Full Text] [Related]
5. [Control of oral anticoagulation. Current concepts].
Aguilar CA; Hurtado Monroy R; Gaspar Hernández J
Rev Invest Clin; 1989; 41(4):371-4. PubMed ID: 2698502
[TBL] [Abstract][Full Text] [Related]
6. [Control of the treatment with oral anticoagulants and prothrombin time].
Marzouka E
Rev Med Chil; 1991 Oct; 119(10):1160-4. PubMed ID: 1845211
[TBL] [Abstract][Full Text] [Related]
7. Oral anticoagulant monitoring by laboratory or near-patient testing: what a clinician should be aware of.
Tripodi A; Breukink-Engbers WG; van den Besselaar AM
Semin Vasc Med; 2003 Aug; 3(3):243-54. PubMed ID: 15199457
[TBL] [Abstract][Full Text] [Related]
8. [Present and future of oral anticoagulants].
Meschengieser SS; Casais P; Sánchez Luceros A; Lazzari MA
Medicina (B Aires); 2000; 60(1):139-42. PubMed ID: 10835711
[TBL] [Abstract][Full Text] [Related]
9. Prothrombin time in liver failure: time, ratio, activity percentage, or international normalized ratio?
Robert A; Chazouillères O
Hepatology; 1996 Dec; 24(6):1392-4. PubMed ID: 8938167
[TBL] [Abstract][Full Text] [Related]
10. [The international normalization ratio in the monitoring of oral anticoagulant therapy].
Sansores-García L; Majluf-Cruz AS; Vargas-Vorácková F; Labardini-Méndez J
Rev Invest Clin; 1993; 45(5):463-7. PubMed ID: 8134728
[TBL] [Abstract][Full Text] [Related]
11. [Current biological surveillance of oral anticoagulant treatment].
Helft G; Vacheron A; Samama MM
Arch Mal Coeur Vaiss; 1995 Jan; 88(1):85-9. PubMed ID: 7646254
[TBL] [Abstract][Full Text] [Related]
12. Discrepant sensitivity of thromboplastin reagents to clotting factor levels explored by the prothrombin time in patients on stable oral anticoagulant treatment: impact on the international normalized ratio system.
Testa S; Morstabilini G; Fattorini A; Galli L; Denti N; D'Angelo A
Haematologica; 2002 Dec; 87(12):1265-73. PubMed ID: 12495900
[TBL] [Abstract][Full Text] [Related]
13. Oral anticoagulant initiation: rationale for the use of warfarin dosing nomograms.
Crowther MA
Semin Vasc Med; 2003 Aug; 3(3):255-60. PubMed ID: 15199458
[TBL] [Abstract][Full Text] [Related]
14. Oral anticoagulant therapy and international normalized ratios in swine.
McGlasson DL; Brickey DA; Doe RH
Lab Anim Sci; 1998 Aug; 48(4):371-3. PubMed ID: 10090045
[TBL] [Abstract][Full Text] [Related]
15. Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome.
Della Valle P; Crippa L; Garlando AM; Pattarini E; Safa O; Viganò D'Angelo S; D'Angelo A
Haematologica; 1999 Dec; 84(12):1065-74. PubMed ID: 10586206
[TBL] [Abstract][Full Text] [Related]
16. Control of oral anticoagulant therapy.
Biemer JJ
Ann Clin Lab Sci; 1988; 18(6):421-8. PubMed ID: 3239946
[TBL] [Abstract][Full Text] [Related]
17. Point-of-care monitoring of oral anticoagulation therapy in children. Comparison of the CoaguChek XS system with venous INR and venous INR using an International Reference Thromboplastin preparation (rTF/95).
Greenway A; Ignjatovic V; Summerhayes R; Newall F; Burgess J; DeRosa L; Monagle P
Thromb Haemost; 2009 Jul; 102(1):159-65. PubMed ID: 19572081
[TBL] [Abstract][Full Text] [Related]
18. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment.
D'Angelo A; Della Valle P; Crippa L; Fattorini A; Pattarini E; Viganò D'Angelo S
Haematologica; 2002 Oct; 87(10):1074-80. PubMed ID: 12368163
[TBL] [Abstract][Full Text] [Related]
19. Use of EDTA samples for prothrombin time measurement in patients receiving oral anticoagulants.
Horsti J
Haematologica; 2001 Aug; 86(8):851-5. PubMed ID: 11522542
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a portable prothrombin time monitor for home use by patients who require long-term oral anticoagulant therapy.
Anderson DR; Harrison L; Hirsh J
Arch Intern Med; 1993 Jun; 153(12):1441-7. PubMed ID: 8512435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
